OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A triple combination gemcitabine + romidepsin + cisplatin to effectively control triple-negative breast cancer tumor development, recurrence, and metastasis
Pawat Pattarawat, Jessica T. Hunt, Jacob Poloway, et al.
Cancer Chemotherapy and Pharmacology (2021) Vol. 88, Iss. 3, pp. 415-425
Open Access | Times Cited: 8
Pawat Pattarawat, Jessica T. Hunt, Jacob Poloway, et al.
Cancer Chemotherapy and Pharmacology (2021) Vol. 88, Iss. 3, pp. 415-425
Open Access | Times Cited: 8
Showing 8 citing articles:
Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer
Bi Lian, Xiaosong Chen, Kunwei Shen
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Bi Lian, Xiaosong Chen, Kunwei Shen
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives
Ibrahim S. Alalhareth, Saleh M. Alyami, Abdulrhman Alshareef, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 207-207
Open Access
Ibrahim S. Alalhareth, Saleh M. Alyami, Abdulrhman Alshareef, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 207-207
Open Access
Histone acetylation modulators in breast cancer
Xueying Yuan, Jeffrey M. Rosen
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Xueying Yuan, Jeffrey M. Rosen
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Clinical Applications of HDAC Inhibitors as Anticancer Agents in Prostate, Breast, Ovarian, and Cervical Cancers
Saad Bakrim, Farah Atifi, Nasreddine El Omari, et al.
ChemistrySelect (2025) Vol. 10, Iss. 12
Closed Access
Saad Bakrim, Farah Atifi, Nasreddine El Omari, et al.
ChemistrySelect (2025) Vol. 10, Iss. 12
Closed Access
The development of molecular typing in canine mammary carcinomas
Hui-Hua Zheng, Chong-Tao Du, Xin-Yue Tang, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 9, pp. 8943-8951
Closed Access | Times Cited: 4
Hui-Hua Zheng, Chong-Tao Du, Xin-Yue Tang, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 9, pp. 8943-8951
Closed Access | Times Cited: 4
Therapeutic targeting of DNA damage repair pathways guided by homologous recombination deficiency scoring in ovarian cancers
Chunxiu Lin, Peng Liu, Chaowen Shi, et al.
Fundamental and Clinical Pharmacology (2022) Vol. 37, Iss. 2, pp. 194-214
Closed Access | Times Cited: 3
Chunxiu Lin, Peng Liu, Chaowen Shi, et al.
Fundamental and Clinical Pharmacology (2022) Vol. 37, Iss. 2, pp. 194-214
Closed Access | Times Cited: 3
RNA Nanotechnology for Codelivering High-Payload Nucleoside Analogs to Cancer with a Synergetic Effect
Xin Li, Kai Jin, You-Cheng Liao, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 11, pp. 5690-5702
Closed Access
Xin Li, Kai Jin, You-Cheng Liao, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 11, pp. 5690-5702
Closed Access
Applications of macrocyclic molecules in cancer therapy: Target cancer development or overcome drug resistance
Xiaoling Song, Yifan Wu, QU Xiao-juan, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 1
Xiaoling Song, Yifan Wu, QU Xiao-juan, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 1
